New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors

Aristotelis Bamias^*, Axel Merseburger, Yohann Loriot, Nicholas James, Ernest Choy, Daniel Castellano, F. Lopez-Rios, Fabio Calabrò, Mario Kramer, Guillermo De Velasco, Roubini Zakopoulou, Kimon Tzannis, Cora N. Sternberg

^*Corresponding author for this work